Quotables
"Everyone acquainted with the subject will recognize it as a conspicuous failure."
Henry Morton, president of the Stevens Institute of Technology ; Said in 1880 about the light bulb
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7256312 | Method for producing aminoalkoxy benzylamines and aminoalkoxy benzonitriles as intermediates The invention relates to a process for preparing 4-[aminoalkoxy]benzylamines of the general formula (I) by catalytically hydrogenating 4-[aminoalkoxy]benzonitriles of the general formula (II) ... | 08/14/2007 |
| 7241625 | Carbonyl compound scavenger and method of quantifying carbonyl compound using the same A carbonyl compound scavenger comprising a mineral acid salt of a benzylhydroxyamine-based compound of the formula (1) and at least one adsorbent selected from the group consisting of silica gel, alumina, cellulose and activated carbon: | 07/10/2007 |
| 7223794 | Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase There are provided novel compounds of formula (I), wherein R1, R2, R3, T, U, X, Y, V and W are as defined in the specification, and pharmaceutically acceptable salts thereof, and enantiomers and racemates thereof; together with proce... | 05/29/2007 |
| 6964976 | Amino alcohol derivatives Compounds of formula (I) which exhibit excellent immune suppression activity, pharmacologically acceptable salts thereof, esters thereof or other derivatives: wherein R1 and R2 are a hydrogen atom... | 11/15/2005 |
| 6953797 | Use of phenylheteroalkylamine derivatives There is disclosed the use of a compound of formula (I), wherein R1, R2, X, Y, V, W and Z are as defined in the specification, and pharmaceutically acceptable salts, enantiomers or racemates thereof, in the manufacture of a medicament, for the ... | 10/11/2005 |
| 6914074 | Substituted phenyl naphthalenes as estrogenic agents This invention provides estrogen receptor modulators of formula I, having the structure wherein R1, R2, R3, R4, R5, R6, R7, R | 07/05/2005 |
| 6906223 | Method for the production of trioxime derivatives The present invention relates to a process for preparing trioxime derivatives of the formula I in which the substituents R1 and R2 are identical or different and each is cyano, alkyl, haloalkyl or... | 06/14/2005 |
| 6900243 | Phenylheteroalkylamine derivatives There are provided novel compounds of formula (I), wherein R1, R2, X, Y, V, W and Z are as defined in the specification, and pharmaceutically acceptable salts thereof, and enantiomers and racemates thereof; together with processes for their pre... | 05/31/2005 |
| 6890955 | Aryloxypropanolamine derivatives, method of preparation and applications thereof The invention concerns aryloxypropanolamine derivatives having at least an anti-diabetic and anti-fat activity and their methods of preparation and applications, particularly as human and veterinary medicine and animal food additive. These derivatives comply with th... | 05/10/2005 |
| 6861561 | Substituted aromatic policyclic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity The invention relates to substituted aromatic polycyclic tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and o... | 03/01/2005 |
| 6743939 | Phenylheteroalkylamine derivatives There are provided novel compounds of formula (I), wherein R1, R2, X, Y, V, W and Z are as defined in the specification, and pharmaceutically acceptable salts thereof, and enantiomers and racemates thereof; together with processes for their pre... | 06/01/2004 |
| 6710080 | Substituted 2-dialkylaminoalkylbiphenyl derivatives Substituted 2-dialkylaminoalkylbiphenyl derivatives, processes for their preparation, pharmaceutical compositions comprising these compounds and methods using these compounds for the preparation of medicaments and for the treatment of diseases. ... | 03/23/2004 |
| 6576596 | Substituted 2-benzoyl-cyclohexan-1,3-diones with herbicidal effect The invention relates to 2-benzoylcyclohexane-1,3-diones of the formula I ##STR1## where R1, R2 are each hydrogen, nitro, halogen, cyano, thiocyanato, alkyl, haloalkyl, alkoxyalkyl, alkenyl, alkynyl, --OR5, --OCOR6, ... | 06/10/2003 |
| 6541670 | Aminobenzophenones as inhibitors of IL 1ଲ and TNF- A compound of the general formula I ##STR1## wherein R1 represents a substituent selected from the group consisting of halogen, hydroxy, mercapto, trifluoromethyl, amino, (C1 -C3)alkyl, (C2 -C3)olefin... | 04/01/2003 |
| 6521667 | Calcilytic compounds The present invention features calcilytic compounds. "Calcilytic compounds" refer to compounds able to inhibit calcium receptor activity. Also described are the use of calcilytic compounds to inhibit calcium receptor activity and/or achieve a beneficial e... | 02/18/2003 |
| 6479550 | -sulfenimino acid derivatives -Sulfenimino acid derivatives of formula I ##STR1## including the optical isomers thereof and mixtures of such isomers, wherein A is cycloalkyl, cycloalkenyl, aryl or heteroaryl, each optionally substituted, B is a direct bond or optionally substituted ... | 11/12/2002 |
| 6448293 | Diphenyl ether compounds useful in therapy A compound of general formula (I), or pharmaceutically acceptable salts, solvates or polymorphs thereof; wherein; R1 and R2, which may be the same or different, are hydrogen, C1 -C6 alkyl, (CH2)m... | 09/10/2002 |
| 6437153 | Process for preparing 3-(1-hydroxyphenyl-1-alkoximinomethyl)dioxazines The present invention relates to a novel process for preparing 3-(1-hydroxyphenyl-1-alkoximinomethyl)dioxazines which are known as intermediates for preparing compounds having fungicidal properties (WO 95-04728). Furthermore, the invention relates to nove... | 08/20/2002 |
| 6417215 | Calcilytic compounds Novel calcilytic compounds are provided.... | 07/09/2002 |
| 6392083 | Process for producing salts of cyanobenzylamines A process for producing a salt of a cyanobenzylamine comprising reacting a cyanobenzylamine with an acid. A salt of a cyanobenzylamine can industrially easily be produced and the resulting salt of a cyanobenzylamine has a high bulk density.... | 05/21/2002 |
| 6346518 | Itraconazole and saperconazole stereoisomers The present invention is concerned with the stereoisomeric forms of itraconazole (X=Cl) and saperconazole (X=F), which may be represented by the formula ##STR1## and the pharmaceutically acceptable acid addition salt forms thereof, processes for prep... | 02/12/2002 |
| 6344505 | Mono- and bis-benzotriazolyldihydroxybiaryl UV absorbers Provided is a composition which contains a mono- or bis-benzotriazole compound, an N-oxide thereof, or a mixture of at least two of the preceding compounds. Representative bis-benzotriazole compounds include 3,3'-bis-(2H-benzotriazol-2-yl)-5,5'-di-tert-oc... | 02/05/2002 |
| 6284913 | Selective hydrogenation of a C3-C5 alkyl alchol There is provided lower alkanesulphonate salts of cyanobenzylamines, which salts may be produced via a selective recrystallisation process. The salts may be produced advantageously following the selective hydrogenation of a dicyanobenzene to a cyanobenzyl... | 09/04/2001 |
| 6251925 | Therapeutic biaryl derivatives The present invention relates to therapeutic biaryl derivatives of formula (I), and pharmaceutically acceptable derivatives thereof ##STR1## wherein R1 is a phenyl, naphthyl, pyridyl, thiazolyl, phenoxymethyl, or pyrimidyl group, optionally sub... | 06/26/2001 |
| 6239288 | Biphenyl hydroxy imino butyric acids and their derivatives for treating arthritis Biphenyl butyric acid compounds and derivatives are described as well as acid methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A (72 kD gelatinase) an... | 05/29/2001 |
| 6229047 | Dipole aligned NLO chromophores A nonlinear optical material which is characterized as having a relatively high macroscopic dipole moment achieved through the generally parallel packing of dipolar molecules in a relative orientation to reinforce their dipole moments. The nonlinear optic... | 05/08/2001 |
| 6114277 | Process for preparing cyano group-containing aromatic methylamines The object of the invention is to provide a process for preparing a cyano group-containing methylamine, comprising hydrogenating only one of the two nitrile groups of a aromatic dinitrile, wherein the aromatic dinitrile is reacted a a high conversion rati... | 09/05/2000 |
| 6075049 | Phenylcarbamates, processes and intermediate products for their preparation and their use as pesticides and fungicides Phenylcarbamates of the formula I ##STR1## where the substituents and the index have the following meanings: R is cyano, nitro, trifluoromethyl, halogen, alkyl or alkoxy; m is 0, 1 or 2; R1 is alkyl, alkenyl, alkynyl, cycloalkyl or cycloalkenyl... | 06/13/2000 |
| 6037472 | Matrix metalloprotease inhibitors Compounds of formula (I) ##STR1## and their pharmaceutically acceptable salts inhibit matrix metalloproteases, such as stromelysin, gelatinase, matrilysin and collagenase, and are useful in the treatment of mammals having disease-states alleviat... | 03/14/2000 |
| 5952386 | Dihalopropene compounds, insecticides containing them as active ingredients, and intermediates for their production The present invention provides dihalopropene compounds of the general formula: ##STR1## wherein R1 is C1 -C10 alkyl or the like; L is C(.dbd.O)NH or the like; R2, R3 and R4 are indepen... | 09/14/1999 |
| 5948932 | Phenylacetic acid derivatives, processes and intermediates for use in producing them and agents containing them Phenylacetic acid derivatives of the formula I ##STR1## where the substituents and the index have the following meanings: x is NOCH3, CHOCH3, CHCH3 ; Y is O, NR R1,R independently of one another are hydrogen and... | 09/07/1999 |
| 5905090 | Analogues of the active metabolite of leflunomide Analogues of the active metabolite of leflunomide, and to the use thereof as immunosuppressive and/or antinflammatory agents.... | 05/18/1999 |
| 5847147 | 3-Amino-2-mercaptobenzoic acid derivatives and processes for their preparation Compounds of the formula I ##STR1## and disulfides thereof and salts thereof are important intermediate products for the preparation of compounds having a microbicidal and plant-immunizing action, of the formula III ##STR2## In the compound... | 12/08/1998 |
| 5840764 | Substituted hydroxy-anilino derivatives of cyclobutene-3,4-diones The compound of the formula: ##STR1## wherein R1 is straight chain alkyl, branched chain alkyl, cycloalkyl, hydroxyalkyl, fluoroalkyl, or polyfluoroalkyl; and one of R2, R3 and R4 is hydroxyl and the other ... | 11/24/1998 |
| 5821386 | Compounds for treating cocaine abuse Disclosed are novel compounds which are dopamine reuptake blockers for treating cocaine abuse. The compounds are represented by the following structural formula: ##STR1## R2 is n-propyl, iso-propyl, n-butyl, sec-butyl, or tert-butyl. Phenyl Ring ... | 10/13/1998 |
| 5817834 | Process for the preparation of 2-aryl-5-(perfluoro-alkyl) pyrrole compounds from N-(perfluoroalkyl-methyl) arylimidoyl chloride compounds There is provided a process for the preparation of 2-aryl-5-(perfluoroalkyl)pyrrole compounds from N-(perfluoroalkylmethyl)arylimidoyl chloride compounds. The 2-aryl-5-(perfluoroalkyl)pyrrole compounds are useful for the control of insect and acarid ... | 10/06/1998 |
| 5817877 | Metal-catalyzed amination of organic sulfonates to organic amines A process of preparing an organic amine having at least one unsaturated group, such as an arylamine, involving contacting an unsaturated organic sulfonate, such as an aryl sulfonate, with a reactant amine, such as an alkyl or aryl amine, in the presence o... | 10/06/1998 |
| 5808080 | Selective 댣 adrenergic agonists The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective 댣 adrenergic receptor agonists useful in the treatment of Type II diabet... | 09/15/1998 |
| 5770758 | 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation Compounds of the formula I ##STR1## and disulfides thereof and salts thereof are important intermediate products for the preparation of compounds having a microbicidal and plant-immunizing action, of the formula III ##STR2## In the compound... | 06/23/1998 |
| 5736568 | 2-(aminoalkoxy) phenylalkylamines with antiinflammatory activity Compounds of the formula I ##STR1## including pharmaceutically acceptable salts thereof are disclosed in which R1, R2, R3, and R4 independently represent hydrogen, hydroxy, halo, halogenated alkyl, halogena... | 04/07/1998 |
